Primary Care Webinar 1 – Recognizing hypertrophic cardiomyopathy in primary care: what to look for, what to do and when (First schedule)

Course Overview

This content was accurate at the time of release, 26 March 2023. Accreditation for this course expired on 23 April 2023. If you would still like an activity completion certificate, send your request to [email protected].

This event will take place twice on March 27th, 2023
First schedule: 1pm EDT / 7pm CEST
Second schedule: 7pm EDT / 1am CEST (+1)

This expert webinar is designed to raise awareness for HCM and provide knowledge around HCM diagnosis. It assists primary healthcare professionals to:

  • recognize symptoms that may suggest a diagnosis of HCM​ and physical examination findings that merit further investigation and / or referral to secondary care
  • better describe pharmaceutical treatments for heart failure symptoms and identify potential drug–drug interactions in HCM patients

This webinar is 60 minutes duration.

Target audience

Family/general/internal medicine physicians, nurse practitioners, registered nurses, clinical nurse specialists, physician assistants, pediatricians, pediatric nurses.

Funding disclosure

This activity is supported by educational grant funding from Bristol Myers Squibb and Cytokinetics. Learners may participate in this educational activity free of charge.

  • Introduction to hypertrophic cardiomyopathy (HCM)
  • HCM presentation, patient symptoms, diagnosis, and referral
  • Therapeutic goals and a brief introduction to pharmacotherapies
  • Q&A and closing remarks​

By the end of this activity, attendees will be able to:

  • recognize symptoms that may suggest a diagnosis of HCM​
  • outline ECG and physical examination findings that are suggestive of HCM and merit referral to secondary care, and apply to an example patient​
  • summarize diagnostic differences between HCM and other diseases that can cause left ventricular hypertrophy (LVH) and apply this information to appropriately diagnose patients​
  • identify key drug–drug interactions which should be considered in patients with HCM and comorbidities requiring pharmacological treatment, and apply to an example patient

This continuing education (CE) activity is provided through collaboration between PCM Scientific and AffinityCE. This activity provides CE credit for physicians, physician assistants, nurses and nurse practitioners. A statement of participation is available to other attendees.

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and PCM Scientific. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of up to 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and PCM Scientific. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of up to 1.0 AMA PRA Category 1 Credits™. Physician assistants should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and PCM Scientific. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of up to 1.0 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Continuing Nursing Education is provided for this program through the joint providership between PCM Scientific and AffinityCE. AffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This activity provides a maximum of up to 1.0 contact hours of continuing nursing education credit.

CME Inquiries

For all CME policy-related inquiries, please contact us at [email protected].

Dr Anjali Owens​, MD, Associate Professor of Medicine​, University of Pennsylvania​, has received financial compensation for consulting for Bristol Myers Squibb, Cytokinetics, Pfizer, Edgewise Therapeutics, Renovacor/Rocket, Stealth Biotherapeutics, Lexicon Pharmaceuticals, Tenaya Therapeutics, and received research grants from Bristol Myers Squibb and Cytokinetics.

Dr Lubna Choudhury​, MD, Professor of Medicine​, Northwestern University​, has received research grants from Bristol Myers Squibb and Cytokinetics.

AffinityCE staff, PCM Scientific staff, as well as planners and reviewers have no relevant financial interests to disclose.

Mitigation of relevant financial relationships

AffinityCE adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

  1. Please log in once registered, return to the individual course page and click ‘Start course’.
  2. Take the Pre-learning test. This step is optional but helps us to understand how effective the courses are that we create.
  3. Complete the learning activity (e.g, Live webinar or Case study) and when finished click the ‘Next step’ button underneath the content panel.
  4. Complete the Post-learning test and click the ‘Submit answers’ button at the bottom of the test. This step is mandatory, and you must pass with ≥80% correct responses if you wish to earn CE credit(s).
    You may view your responses along with the correct answers and explanatory information after you submit by clicking ‘Review test answers’.
    You can re-take the test as many times as desired by clicking the ‘Re-take test’ button.
  5. Complete the Course evaluation and click the ‘Submit answers’ button at the bottom of the page. You can complete this in part or in full but your responses help us to understand how effective the courses are that we create.
    Then click the ’Continue course’ button on the right of the page.
  6. At the course completion stage, please click the ‘Confirm complete and request certificate’.
  7. You can now download your CE credit certificate via the ‘Download Certificate’.

If you need any help or assistance, please let us know at [email protected].

NOTE:

  • You will have 30 days from the date of a Live webinar to complete steps 4–7.
  • For all On-demand courses (e.g., Case study), you will be able to earn CE credit for a 12-month period. You will not be able to download a certificate after the CME expiry date.

Here are some external information sources you may find helpful for further reading. Please note that these resources are not affiliated with HCM Academy and by clicking any of these links, you will leave this site.

Physician resources

  1. Excaliper: improve your ECG skills
    https://excaliper.com/
  2. European Society of Cardiology: clinical practice guidelines
    https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Hypertrophic-Cardiomyopathy
  3. HCM Medical Society: professional medical society
    https://hcmsociety.org/
  4. CSANZ: Cardiac Society of Australia and New Zealand
    https://www.csanz.edu.au/

Patient resources

  1. HCMA: Hypertrophic Cardiomyopathy Association
    https://4hcm.org/
  2. Cardiomyopathy UK: HCM online support group
    https://www.cardiomyopathy.org/hcm-online
  3. European Heart Network: community support group
    https://mendedhearts.org/hypertrophic-cardiomyopathy-hcm/
  4. Could it be HCM?: patient information about symptoms
    https://www.coulditbehcm.com/resources